UNICA IRIS Institutional Research Information System

PISTIS, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 191.259
NA - Nord America 6.305
AS - Asia 1.044
SA - Sud America 13
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 198.645
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 189.644
US - Stati Uniti d'America 6.275
CN - Cina 728
UA - Ucraina 547
SE - Svezia 473
SG - Singapore 200
DE - Germania 176
GB - Regno Unito 158
FI - Finlandia 138
FR - Francia 55
VN - Vietnam 46
CA - Canada 27
KR - Corea 22
BE - Belgio 13
IN - India 13
NL - Olanda 11
HK - Hong Kong 10
AT - Austria 9
EU - Europa 9
CZ - Repubblica Ceca 8
BR - Brasile 7
TR - Turchia 7
EG - Egitto 6
RU - Federazione Russa 6
IE - Irlanda 5
IR - Iran 5
JP - Giappone 4
AU - Australia 3
CR - Costa Rica 3
ES - Italia 3
LT - Lituania 3
AR - Argentina 2
CH - Svizzera 2
CL - Cile 2
EE - Estonia 2
IL - Israele 2
KG - Kirghizistan 2
RS - Serbia 2
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 198.645
Salva come PNG Salva come JPEG
Città #
Cagliari 185.545
Uta 3.703
Fairfield 915
Woodbridge 641
Chandler 435
Houston 411
Ashburn 401
Boardman 391
Ann Arbor 383
Nyköping 339
Wilmington 337
Seattle 332
Cambridge 301
Jacksonville 267
Dearborn 194
Shanghai 121
Santa Clara 112
Singapore 108
Nanjing 104
Beijing 95
New York 86
Boston 83
Helsinki 63
San Diego 52
Dong Ket 46
Nanchang 38
Guangzhou 36
Milan 33
Hebei 32
Redwood City 29
Shenyang 29
Los Angeles 28
London 25
Rome 25
Mountain View 24
Jiaxing 22
Seoul 20
Hefei 19
Jinan 18
Norwalk 18
Tianjin 18
Toronto 18
Munich 17
Brussels 13
Kunming 13
Verona 13
Auburn Hills 12
Orange 12
San Mateo 12
Sèlegas 12
Augusta 11
Changsha 10
Hong Kong 10
Taizhou 10
Washington 10
Wuhan 10
Zhengzhou 10
Leawood 9
Ningbo 9
Sassari 9
Frankfurt am Main 8
Monmouth Junction 8
Phoenix 8
Quartu Sant'elena 8
Vienna 8
Brno 7
Cairo 6
Kilburn 6
Atlanta 5
Borås 5
Chicago 5
Dublin 5
Iglesias 5
Kocaeli 5
Pune 5
Shenzhen 5
Tappahannock 5
Torino 5
Villacidro 5
Araraquara 4
Falls Church 4
Fremont 4
Hounslow 4
Mondolfo 4
Shaoxing 4
Amsterdam 3
Ardabil 3
Baotou 3
Brampton 3
Chiswick 3
Detroit 3
Jinhua 3
Livorno 3
Marcon 3
Montague 3
New Bedfont 3
Parma 3
Pisa 3
Piscataway 3
Prescot 3
Totale 196.282
Salva come PNG Salva come JPEG
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.609
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.488
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.026
Maternal immune activation disrupts dopamine system in the offspring 3.995
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.386
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.274
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.271
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 2.970
null 2.940
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 2.912
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.712
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.640
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.569
null 2.498
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.467
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.429
null 2.394
Effects of maternal immune activation on dopamine activity in male and female offspring 2.333
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.326
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.245
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.238
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.205
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.128
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.100
Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: Involvement of the endocannabinoid system 2.087
Trattamenti farmacologici per la dipendenza da nicotina 1.963
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 1.948
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 1.916
The role of nuclear hormone receptors in cannabinoid function 1.881
Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System 1.863
Pharmacological treatments for nicotine dependence 1.838
Opposite responses to aversive stimuli in lateral habenula neurons 1.822
Exposure to tobacco smoke during the early postnatal period modifies receptors and enzymes of the endocannabinoid system in the brainstem and striatum in mice 1.767
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors 1.764
Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2 1.740
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.740
Neurobiologia della dipendenza da nicotina 1.714
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.707
Cannabinoid withdrawal: where does the hypodopaminergic state come from? 1.698
Roles of N-acylethanolamines in brain functions and neuropsychiatric diseases 1.695
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.692
Characterization of wild-type (R100R) and mutated (Q100Q) GABA(A) alpha(6) subunit in Sardinian alcohol non-preferring rats (sNP) 1.677
The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding 1.621
Neurobiology of nicotine addiction 1.585
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.567
Preclinical studies of cannabis addiction − relationships between the endocannabinoid and dopamine systems 1.543
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings 1.518
Environmental Tobacco Smoke During the Early Postnatal Period of Mice Interferes With Brain 18 F-FDG Uptake From Infancy to Early Adulthood – A Longitudinal Study 1.488
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.488
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features and emerging specificities of the two major endocannabinoids 1.475
The endocannabinoid system and nondrug rewarding behaviours 1.386
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.360
Inhibition of anandamide hydrolysis differentially modulates cocaine-induced effects on rat mesolimbic system 1.351
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.325
Inhibition of anandamide hydrolysis antagonizes nicotine effects on neurons in the nucleus accumbens shell in the rat 1.305
Peroxisome proliferator activated receptors type alpha modulate nicotine effects in the rat ventral tegmental area 1.283
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.282
Neurobiological mechanisms of cannabinoid addiction 1.206
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.205
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.140
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.072
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.053
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.026
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? 1.016
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.011
Endocannabinoids and the processing of value-related signals 1.003
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 967
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 957
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 891
null 850
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 845
null 841
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 819
Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction 810
null 800
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology 787
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 750
null 747
Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors 720
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 705
N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance 697
Dietary Phospholipid-Bound Conjugated Linoleic Acid and Docosahexaenoic Acid Incorporation Into Fetal Liver and Brain Modulates Fatty Acid and N-Acylethanolamine Profiles 694
From surface to nuclear receptors: the endocannabinoid family extends its assets 692
Stereoselectivity of NCS-382 binding to gamma-hydroxybutyrate (GHB) receptor in the rat brain 656
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 651
Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system 645
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 631
Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition 602
The R100Q mutation of the GABA(A) alpha(6) receptor subunit may contribute to voluntary aversion to ethanol in the sNP rat line 598
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 595
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 577
Identification of metabolic biomarkers of chronic vagus nerve stimulation (VNS) in subjects with drug-resistant epilepsy (DRE) 575
Braking Dopamine Systems: A New GABA Master Structure for Mesolimbic and Nigrostriatal Functions 572
Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study 549
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 545
Chronic administration of l-sulpiride at low doses reduces A10 but not A9 somatodentritic dopamine autoreceptor sensitivity 464
Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation 462
Cognitive performance in aged rats is associated with differences in distinctive neuronal populations in the ventral tegmental area and altered synaptic plasticity in the hippocampus 451
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study 424
Older people: forgotten victims amid the Ukrainian humanitarian disaster 410
Totale 188.955
Salva come PNG Salva come JPEG
Categoria #
all - tutte 238.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 238.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016.050 0 0 0 0 0 8.474 4.196 873 562 589 577 779
2020/202141.818 1.144 1.558 1.599 12.763 8.894 4.482 3.079 2.280 1.003 1.933 2.021 1.062
2021/202211.101 1.050 879 586 682 1.013 908 564 469 602 1.328 1.738 1.282
2022/202314.067 990 1.397 1.327 1.089 1.323 1.647 733 1.299 1.120 1.051 1.430 661
2023/202449.892 661 572 541 856 1.483 2.459 2.645 1.114 938 903 1.646 36.074
2024/202517.340 3.853 4.782 2.869 3.011 1.650 1.175 0 0 0 0 0 0
Totale 199.000